Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat

Clinical trial NCT00791011 · COMPLETED

Trial details

NCT number: NCT00791011
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin's Lymphoma Low Grade Lymphoma Lymphoma Mantle Cell Lymphoma Non-Hodgkin's Lymphoma Diffuse Large Cell Lymphoma

Start date: 2008-02-01
Primary completion: 2010-07-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.